Figure Legends

Figure 1. CONSORT diagram of participants’ flow.
Figure 2. Procedure of the present study.
Figure 3. Effects of open-label placebo (OLP) vs. treatment as usual (TAU) on a) the severity of allergic symptoms, b) the frequency of allergic symptoms, and c) allergy-related impairment.
Figure 4. Effects of open-label placebo vs. treatment as usual on the frequency of different clusters of allergic symptoms.